Company intelligence / Profile preview

CDC IV

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

CDC IV, LLC is a specialty finance company and investment vehicle managed by Clinical Development Capital, an affiliate of the venture capital firm Care Capital. The company provides non-dilutive capital to biotechnology and pharmaceutical firms to support the clinical development of late-stage drug candidates, particularly Phase III trials. CDC IV is best known for its 2005 Clinical Development and License Agreement with BioDelivery Sciences International (BDSI), through which it provided funding for the development of ONSOLIS (fentanyl buccal soluble film). In exchange for its investment, CDC IV holds rights to milestone payments and ongoing royalties on the net sales of the products it funds.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Investors

Partnerships

BioDelivery Sciences International

Beyond the preview

Go deeper on CDC IV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDC IV.

Explore the full profile